Biochemistry, Food Science and Nutrition,, The Robert H. Smith Faculty of Agriculture, Food and Environment, The Hebrew University of Jerusalem, Reẖovot, Central, Israel
Mrs. Neriya Levran
Biochemistry, Food Science and Nutrition,, The Robert H. Smith Faculty of Agriculture, Food and Environment, The Hebrew University of Jerusalem, Reẖovot, Central, Israel
Objective: The aim of this study was to evaluate the macronutrient and micronutrient intake and status in youth with type 1 diabetes mellitus (T1DM) following the consumption of a low-carbohydrate diet (LCD). Research Methods and Procedures: In a prospective intervention clinical trial, adolescents with T1DM using a continuous glucose monitoring device were enrolled. Following a cooking workshop, each participant received a personalized diet regime based on LCD (50–80 g carbohydrate/day). A Food Frequency Questionnaire was administered, and laboratory tests were taken before and 6 months following the intervention. Twenty participants were enrolled. Results: The median age was 17 years (15; 19), and the median diabetes duration was 10 years (8; 12). During the six-months intervention, carbohydrate intake decreased from 266 g (204; 316) to 87 g (68; 95) (p = 0.004). Energy intake, the energy percent from ultra-processed food, and fiber intake decreased (p = 0.001, p = 0.024, and p < 0.0001, respectively). These changes were accompanied by declines in BMI z-score (p = 0.019) and waist-circumference percentile (p = 0.007). Improvement was observed in the median HbA1c from 8.1% (7.5; 9.4) to 7.7% (6.9; 8.2) (p = 0.021). Significant declines below the DRI were shown in median intake levels of iron, calcium, vitamin B1, and folate. Conclusions: The LCD lowered ultra-processed food consumption, BMI z-scores and the indices of central obesity. However, LCDs require close nutritional monitoring due to the possibility of nutrient deficiencies.
The Mediterranean diet (MED) is highly recommended. Medical nutrition therapy is the cornerstone of diabetes treatment. The primary outcome was to evaluate the change in micronutrient intake of youth with type 1 diabetes before and after a 6-month MED intervention; we also assessed adherence and glycemic control. Twenty adolescents, median age 18 years (interquartile range: 15.5–21), median diabetes duration 9 years (7–14), using continuous glucose monitoring devices, received personalized diet regimes based on MED. At 6 months post-intervention, the caloric intake remained unchanged; however, the carbohydrate proportion was lower (p = 0.058), and the intakes of some monounsaturated fats increased (p = 0.049). Sodium intake exceeded the recommended daily allowance by 250% (p = 0.653), before and after the intervention. For blood glucose, the percent TIR (time-in-range, 70–180 mg/dL) improved from 52% (38–60) to 63% (47–71) (p = 0.047). The total insulin dose decreased marginally, from 0.76 u/kg (0.64–0.97) to 0.72 u/kg (0.61–0.89) (p = 0.067). BMI z-score and waist circumference did not change (p = 0.316 and p = 0.161, respectively). Diastolic blood pressure percentile decreased from 73% (68–88) to 69% (50–79) (p = 0.028), and LDL cholesterol from 114 mg/dL (105–134) to 104 mg/dL (96–124) (p = 0.059). The Israeli Mediterranean diet screener score increased, from 8 (7–11) to 13 points (12–14) (p < 0.001). The MED-based intervention in youth with type 1 diabetes is feasible and leads to improvement in monounsaturated fat intake, TIR, and diastolic blood pressure. Other parameters show no change (caloric intake, BMI, and HbA1c).
Aim: Low‐carbohydrate (LC) diets have gained popularity. We compared glycaemic and metabolic parameters following an LC versus a Mediterranean (MED) diet in adolescents and youths with type 1 diabetes.Methods: In a six‐month, open‐label, randomised trial, 40 individuals were assigned to either diet. Glycaemic outcomes, based on continuous glucose monitoring, included per cent time of blood glucose in the range [3.9–10.0 mmol/L (70–180 mg/dL)] and haemoglobin A1c (HbA1c).Results: Twenty‐eight (70%) were females. The median age was 18 years. After 6 months, the median time in range increased from 47% to 58% in the LC and from 52% to 64% in the MED diet group (p = 0.98). The delta values for the time in range were 16% and 7% for the respective groups (p = 0.09). The percentage of time >13.9 mmol/L (>250 mg/dL) improved more in the LC diet than in the MED diet group: −10% vs. −2% (p = 0.005). The percentage of time <3.0 mmol/L (<54 mg/dL) was comparable. The delta HbA1c improved in both groups: −0.7% vs. −0.1% (p = 0.02). Changes in BMI Z‐score and lipid levels were similar.Conclusion: Both diets improved glycaemic outcomes in adolescents and youths with type 1 diabetes, without increasing hypoglycaemia or cardiovascular risk factors, indicating comparable safety and efficacy.
Background: The metabolic transition from catabolism to anabolism is a key determinant of recovery in critical illness and should guide nutritional therapy. However, no validated clinical marker currently exists to identify this transition, and current clinical practice relies on calendar-based recommendations. We aim to develop and preliminarily validate a physiology-based, trajectory-driven model to detect the metabolic transition window in critically ill patients. Methods: We conducted a retrospective cohort study in a tertiary-care general ICU. A daily insulin resistance index (IRI) was computed from glucose and insulin data and corrected for steroid exposure. Transition was defined as a ≥ 30% sustained drop in IRI after its peak, together with ≥ 2 of 8 physiologic recovery criteria (lactate, noradrenaline, vasopressin, adrenaline, inflammatory markers-WBC, %neutrophils, CRP, and albumin). Associations with 90-day mortality and caloric exposure were evaluated using Kaplan–Meier analysis and multivariable landmark Cox models. Results: The cohort included 2,350 patients (age 59.8 ± 16.5 years; SOFA 11.7 ± 3.9; 82% mechanically ventilated). A metabolic transition was identified in 94% of patients, with ~ 60% transitioning by ICU day 3. Transition by day 3 was associated with lower 90-day mortality (HR 0.72, 95% CI 0.65–0.81). Patients who never transitioned had substantially higher mortality. High caloric delivery (≥ 1.0 kcal/kg/h for ≥ 24 h) before transition was independently associated with increased 90-day mortality (OR 1.25, 95% CI 1.01–1.55), with a dose–response pattern. In contrast, high caloric delivery based on calendar timing failed to demonstrate a similar pattern. Conclusions: We developed and validated a physiological model for detecting metabolic transition in critical illness and showed that transition occurs early and strongly predicts survival. Higher caloric delivery before transition is associated with increased mortality, supporting nutrition strategies aligned with physiological recovery rather than fixed calendar days.
8 November 2024 in Diabetes Technology & Therapeutics
Background: We assessed real-life glycemic outcomes and predictors of composite measures of optimal glycemic control in children and adolescents with type 1 diabetes (T1D) during their initial 12 months of the MiniMed™ 780G use. Methods: This prospective observational multicenter study collected demographic, clinical, and 2-week 780G system data at five time points. Optimal glycemic control was defined as a composite glycemic control (CGC) score requiring the attainment of four recommended continuous glucose monitoring (CGM) targets, as well as the glycemia risk index (GRI) of hypoglycemia and hyperglycemia and composite CGM index (COGI). Outcome measures included longitudinal changes in multiple glycemic parameters and CGC, GRI, and COGI scores, as well as predictors of these optimal measures. Results: The cohort included 93 children, 43% girls, with a median age of 15.1 years (interquartile range [IQR] 12.9,17.0). A longitudinal analysis adjusted for age and socioeconomic index yielded a significant improvement in glycemic control for the entire cohort ( ptime < 0.001) after the transition to 780G. The mean hemoglobin A1c (HbA1c) (SE) was 8.65% (0.12) at baseline and dropped by >1% after 1 year to 7.54% (0.14) ( ptime < 0.001). Optimal glycemic control measures improved at 12 months post 780G; CGC improved by 5.6-fold ( P < 0.001) and was attained by 24% of the participants, the GRI score improved by 10-fold ( P = 0.009) and was achieved by 10% of them, and the COGI improved by 7.6-fold ( P < 0.001) and was attained by 20% of them. Lower baseline HbA1c levels and increased adherence to Advanced Hybrid Closed-Loop (AHCL) usage were predictors of achieving optimal glycemic control. Conclusions: The AHCL 780G system enhances glycemic control in children and adolescents with T1D, demonstrating improvements in HbA1c and CGM metrics, albeit most participants did not achieve optimal glycemic control. This highlights yet ongoing challenges in diabetes management, emphasizing the need for continued proactive efforts on the part of health care professionals, youth, and caregivers.